61,877 XNAS Volume
XNAS 22 Apr, 2025 4:00 PM (EDT)
Board Meeting
The next board meeting for BioHarvest Sciences Inc is on 30 Apr 2025 for the purpose of BioHarvest Sciences Inc Annual General Meeting for 2025
See details
BioHarvest Sciences Inc Key Metrics
Select
All financials are in USD Million and price data in USD
VIEW MORE
Not Eligible
Expensive Valuation
No Score Avaliable
Check Before You Buy
VIEW FULL CHECKLISTMedium rank
4Positive6Negative
40.0% Pass in checklist
Check P/E Buy Sell Zone
This stock has negative PE
BioHarvest Sciences Inc Stock Price Analysis
Day Price Range | 5.9 (LTP) 5.56 LowHigh |
BioHarvest Sciences Inc Live Price Chart
Switch to TradingView
Fetching data ...
Revenue forecast
Hit
BioHarvest Sciences Inc's Revenue was higher than average estimate 1 time in past 1 year
EPS forecast
Current EPS
Avg. Estimate
Hit
EPS is expected to grow by 71.2% in FY25
Consensus Recommendation
2 ANALYST Recommendations
BUY
The consensus recommendation from 2 analysts for BioHarvest Sciences Inc is BUY
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get BioHarvest Sciences Inc Stock Analysis
BioHarvest Sciences Inc stock analysis with key metrics, changes, and trends.
BioHarvest Sciences Inc Metric | VALUE | CHANGE % | TREND | ANALYSIS | |
---|---|---|---|---|---|
Annual Revenue | $25.19 M | 98.77% | positive |
| |
Annual Net Profit | $12.91 M | 2.78% | negative |
| |
Price to Earning Ratio | -7.89 | - | negative |
| |
Quarterly Revenue | $7.28 M | 61.02% | positive |
| |
Quarterly Net profit | $2.96 M | 59.14% | positive |
| |
Institutional Holding | 0.72 % | 0.21% | positive |
|
Loading data..
BioHarvest Sciences Inc - Company Profile
What does BioHarvest Sciences Inc do?
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.
BioHarvest Sciences Inc Management structure
All Gross Remunerations are in USD
BioHarvest Sciences Inc Board of directors
All Gross Remunerations are in USD